INS and type 2 diabetes mellitus: Studies have shown that clinical characteristics of T2DM, including longer duration of T2DM, exogenous insulin therapy, vascular complications, and poorer glycemic control, are associated with lower bone turnover and increased fractures, particularly in the hip and distal limbs, either directly or due to negative effects on the skeleton (9, 10).